Sloan-kettering Institute for Cancer Research

Ouatek Ouerfelli

Scott D Kuduk

Samuel J Danishefsky

Neal Rosen

Laura Sepp-Lorenzino

Furzhong F Zheng

Bifunctional molecules comprising two hsp-binding moieties which bind to hspin the pocket to which ansamycin antibiotics bind connected via a linker are effective for inducing the degradation and/or inhibition of HER-family tyrosine kinases. For example, a compound of two geldanamycin moities joined by a four-carbon linker provides selective degradation of HER-family tyrosine kinases, without substantially affecting other kinases. These compounds can be used for treatment of HER-positive cancers with reduced toxicity, since these compounds potently kill cancer cells but affect fewer proteins than geldanamycin.

Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases

Bifunctional molecules comprising two hsp-binding moieties which bind to hsp90 in the pocket to which ansamycin antibiotics bind connected via a linker are effective for inducing the degradation and/or inhibition of HER-family tyrosine kinases. For example, a compound of two geldanamycin moities joined by a four-carbon linker provides selective degradation of HER-family tyrosine kinases, without substantially affecting other kinases. These compounds can be used for treatment of HER-positive cancers with reduced toxicity, since these compounds potently kill cancer cells but affect fewer proteins than geldanamycin.

Growing community of inventors

New York, NY, United States of America

Ouatek Ouerfelli